{"Title": ["The Math Shows IHI Can Go To $287", "3 Medical-Supply Stocks You Should Own Besides Medtronic", "LeMaitre Vascular (LMAT) Q1 2020 Earnings Call Transcript", "3 Exciting Healthcare Stocks", "LeMaitre Vascular (LMAT) Q4 2019 Earnings Call Transcript", "Validea's Top Five Healthcare Stocks Based On Motley Fool - 1/19/2020", "Validea Motley Fool Strategy Daily Upgrade Report - 1/4/2020", "Commit To Purchase LeMaitre Vascular At $30, Earn 10.8% Annualized Using Options", "The Math Shows IHI Can Go To $287", "LeMaitre Vascular (LMAT) Q3 2019 Earnings Call Transcript", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 20, 2019", "LeMaitre Vascular (LMAT) Q2 2019 Earnings Call Transcript", "Healthcare: 3 Little-Known Medical Device Makers", "The Math Shows IHI Can Go To $247", "LeMaitre Vascular (LMAT) Q1 2019 Earnings Call Transcript", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for March 21, 2019", "Healthcare Stocks That Hit New Highs ( GSK,BIO,EPIX,...)", "Validea Martin Zweig Strategy Daily Upgrade Report - 2/21/2019", "LMAT Makes Bullish Cross Above Critical Moving Average", "Why LeMaitre Vascular Is Soaring", "Mid-Afternoon Market Update: Crude Oil Up 1.5%; Kandi Technologies Shares Spike Higher", "Mid-Day Market Update: LeMaitre Vascular Surges Following Strong Q4 Results; Sienna Biopharmaceuticals Shares Slide", "LeMaitre Vascular inc (LMAT) Q4 2018 Earnings Conference Call Transcript", "LeMaitre Vascular (LMAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "LeMaitre Vascular Reaches Analyst Target Price", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 19, 2018", "Analysts Predict 17% Gains Ahead For The Holdings of IJT", "3 Top Healthcare Stocks to Buy in October", "LeMaitre Vascular (LMAT) Meets Q3 Earnings Estimates", "Commit To Purchase LeMaitre Vascular At $30, Earn 5.6% Annualized Using Options", "5 Healthcare Stocks That Are Down, But Not Out!", "This Company Proves That Thinking Small Can Pay Off Big", "3 Top Healthcare Stocks to Buy Right now", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 21, 2018", "Validea's Top Five Healthcare Stocks Based On Motley Fool - 7/15/2018", "Validea Motley Fool Strategy Daily Upgrade Report - 7/11/2018", "3 Unknown but Amazing Dividend Stocks", "Validea's Top Five Healthcare Stocks Based On Motley Fool - 6/17/2018", "Validea Motley Fool Strategy Daily Upgrade Report - 6/14/2018", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 21, 2018", "3 Small-Cap Healthcare Stocks for Your Watch List", "Validea Martin Zweig Strategy Daily Upgrade Report - 4/27/2018", "Here's Why LeMaitre Vascular Inc. Is Falling Today", "Mid-Morning Market Update: Markets Open Higher; Facebook Profit Tops Expectations", "Mid-Afternoon Market Update: Dow Rises 250 Points; Chipotle Shares Spike Higher", "LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out?", "Validea's Top Five Healthcare Stocks Based On Motley Fool - 4/15/2018", "Validea's Top Five Healthcare Stocks Based On Martin Zweig - 4/15/2018", "Validea Peter Lynch Strategy Daily Upgrade Report - 4/27/2018", "Validea Martin Zweig Strategy Daily Upgrade Report - 4/27/2018", "Here's Why LeMaitre Vascular Inc. Is Falling Today", "Mid-Morning Market Update: Markets Open Higher; Facebook Profit Tops Expectations", "Mid-Afternoon Market Update: Dow Rises 250 Points; Chipotle Shares Spike Higher", "LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out?", "Validea's Top Five Healthcare Stocks Based On Motley Fool - 4/15/2018", "Validea's Top Five Healthcare Stocks Based On Martin Zweig - 4/15/2018", "Validea Peter Lynch Strategy Daily Upgrade Report - 4/27/2018", "3 Top Healthcare Stocks to Buy Right Now", "Validea Motley Fool Strategy Daily Upgrade Report - 1/13/2018", "Validea Motley Fool Strategy Daily Upgrade Report - 12/20/2017", "Validea Motley Fool Strategy Daily Upgrade Report - 12/5/2017", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 21, 2017", "Validea Motley Fool Strategy Daily Upgrade Report - 11/18/2017", "3 Unknown, but Amazing, Dividend Stocks", "Validea Motley Fool Strategy Daily Upgrade Report - 2/2/2018", "Top-Rated Stocks Near Buy Point With Earnings Due: Inogen", "Why LeMaitre Vascular Inc. Is Plunging Today", "Integra Lifesciences Hld Earns RS Rating Upgrade", "Qiagen Shows Improved Relative Strength; Still Shy Of Benchmark", "Resmed Shows Rising Relative Price Performance; Still Shy Of Key Benchmark", "Stocks To Watch Ahead Of Earnings: Inogen", "Stryker (SYK) to Gain From Solid Portfolio and Acquisitions", "Stocks With Rising Relative Strength: MiMedx", "Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength", "Stocks With Rising Relative Strength: Penumbra", "Neogen Earns Membership In 95-Plus Composite Rating Club", "5 MedTech Stocks to Pick for Stellar Returns", "5 MedTech Stocks to Pick for Stellar Returns", "3 Dividend Healthcare Stocks", "5 Top-Ranked MedTech Growth Stocks for Solid Returns", "Stryker (SYK) to Gain From Solid Portfolio and Acquisitions", "Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength", "Stocks With Rising Relative Strength: Penumbra", "LeMaitre Vascular (LMAT) Worth a Look: Stock Jumps 19.5%", "Mid-Day Market Update: Boston Beer Surges On Earnings Beat; Destination Maternity Shares Slide", "Health Care Sector Update for 07/28/2017: LMAT,CYTR,ATNM", "3 Under-the-Radar Stocks in the Healthcare Sector", "Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead", "Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 21, 2017", "Top Ranked Momentum Stocks to Buy for July 31st", "LeMaitre Vascular (LMAT) Worth a Look: Stock Jumps 19.5%", "Mid-Day Market Update: Boston Beer Surges On Earnings Beat; Destination Maternity Shares Slide", "Health Care Sector Update for 07/28/2017: LMAT,CYTR,ATNM", "3 Under-the-Radar Stocks in the Healthcare Sector", "Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead", "Top Ranked Momentum Stocks to Buy for April 28th", "Here's Why LeMaitre Vascular Stock Is Soaring Today", "Mid-Day Market Update: Crude Oil Down 2%; GrubHub Shares Surge On Earnings Beat", "Mid-Afternoon Market Update: LeMaitre Vascular Rises After Strong Q1 Results; Synchronoss Technologies Shares Plunge", "Medical Device Stocks to Beat Estimates this Earnings Season", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for March 20, 2017", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 17, 2016", "Can The Uptrend Continue for LeMaitre Vascular (LMAT)?", "LeMaitre Vascular Buys Restore Flow Allografts for $14M", "Is LeMaitre Vascular (LMAT) Great Growth Stock?", "Mid-Day Market Update: GNC Falls After Weak Q3 Results; Ocwen Financial Shares Surge", "Mid-Afternoon Market Update: TTM Tech Climbs On Earnings Beat; Groupon Shares Plummet", "Mid-Afternoon Market Update: Crude Oil Up 2.2%; OMNOVA Shares Drop On Earnings Miss", "Is LeMaitre Vascular (LMAT) a Great Growth Stock?", "Can the Rally in LeMaitre Vascular (LMAT) Shares Continue?", "LeMaitre (LMAT) Hits a 52-Week High on Strategic Buyout", "3 Reasons Why LeMaitre Vascular (LMAT) is a Great Momentum Stock", "4 Stocks With Strong Technical Patterns", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 18, 2016", "Moving Average Crossover Alert: LeMaitre Vascular (LMAT)", "Will LeMaitre Vascular (LMAT) Continue to Surge Higher?", "CVS Health (CVS) Tops Q2 Earnings, Lags on Revenue, View Up", "Omnicell (OMCL) Tops Q2 Earnings & Revenues, Margins Drag", "LeMaitre Hits 52-Week High on Strong International Presence", "Why Cryolife Inc's Shares Turned Hot Today", "Myriad Genetics: Study Data Drives Growth, Competition Rife", "Illumina, MolecularMD to Co-Develop Oncology Diagnostics", "STERIS: Synergy Health Deal to Drive Growth, Competition Rife", "Medtronic Positive on HeartWare Buy, Covidien Synergies", "Bruker Poised on Product Launches amid Near-Term Risks", "Medtronic to Boost Heart Failure Business with HeartWare Buy", "Cerus (CERS) in Focus: Stock Moves 6% Higher in Session", "FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device", "Hologic: FDA Okays Procleix Zika Virus Test under IND Study", "Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes", "Qiagen's Q1 Results Hit by Currency, Competition Rife", "Hill-Rom Introduces VisiVest, First Connected Airways System", "Hologic's Zika Virus Test Gets FDA Nod for Emergency Use", "AmSurg, Envision Healthcare Set to Merge by 2016-End", "Genomic Health: Can the Liquid Biopsy Test Boost Margins?", "FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device", "Hologic: FDA Okays Procleix Zika Virus Test under IND Study", "Boston Scientific: Restructuring Plan, Global Growth Impress", "PetMed Remains Strong on New Order & Reorder Sales Gain", "Haemonetics: Q4 Hit by Issues in Russia, Currency Woes Stay", "Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay", "Genomic Health Brings Liquid Biopsy Test for Stage IV Cancer", "Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups", "Henry Schein: Q1 Results Strong, Expansion Plans on Track", "Medtronic (MDT) Posts Solid Q4; Covidien Synergy Continues", "Medtronic (MDT) Beats Q4 Earnings & Revenue Estimates", "NuVasive Poised on Solid International Sales, Scope in Spine", "Medtronic (MDT): Will Currency Woes Hurt Q4 As Well?", "Hologic: Q2 Strong on Segmental Expansion, Competition Rife", "Genomic Health (GHDX): Q1 Results Strong, Costs Escalate", "STERIS (STE): Q4 Results Strong, Currency Woes Remain", "Boston Scientific's Full-Body MRI SCS System Gets FDA Nod", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 23, 2016", "Myriad Genetics: Test Revenues Strong, Currency Woes Stay", "VWR Corp Posts Strong Q1 Results; Gross Margins Weak", "Illumina: Q1 Results Hit by Soaring Costs; '16 View Down", "Abaxis (ABAX) Posts Solid Q4 amid International Headwind", "Genomic Health (GHDX): Q1 Results Strong, Costs Escalate", "STERIS (STE): Q4 Results Strong, Currency Woes Remain", "Boston Scientific's Full-Body MRI SCS System Gets FDA Nod", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 23, 2016", "Myriad Genetics: Test Revenues Strong, Currency Woes Stay", "Edwards Lifesciences' Solid Pipeline, Product Suite Impress", "Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes", "Phibro Animal (PAHC) Misses Q3 Earnings on Low Revenues", "Baxter International (BAX) Q1 Earnings, Sales Beat; View Up", "St. Jude Medical (STJ) Q1 Earnings Beat on High HF Sales", "Quest Diagnostics: Expanded Use of HCV Test Services", "GNC Holdings: Retail a Bright Spot, Cash Balance Strong", "Boston Scientific (BSX): International Growth amid CRM Woes", "Edwards Lifesciences' Solid Pipeline, Product Suite Impress", "Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes", "PAREXEL (PRXL): A Strong Buy on Solid Estimate Revisions", "Phibro Animal Declines as FDA Moves to Revoke Mecadox", "AngioDynamics Tops Q3 Earnings, Sales; FY16 View Pruned", "ResMed: Strong Cash Balance, Product Portfolio Drive Growth", "Medtronic's Micra TPS Miniature Pacemaker Gets FDA Nod", "What Makes Eagle Pharmaceuticals (EGRX) a Strong Sell?", "Edwards Lifesciences Up on Positive PARTNER II Trial Data", "Myriad Genetics: Solid Product Suite, Currency Hurts Stock", "Medtronic: 3-Year CoreValve Data Positive in High Risk Study", "Akers Biosciences' Protein Preparation Gets Patent Cover", "Cepheid: Test Menu Expansion Strong, Currency Woes Stay", "Boston Scientific Unveils Stent for Pancreatitis Complications", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for March 17, 2016", "Baxter (BAX) Now a Strong Buy on Solid Estimate Revisions", "FDA Okays Cepheid Xpert Carba-R for Drug-Resistant Genes", "Walgreens Boots Tops Q2 Earnings, Rite Aid Deal in Focus", "LeMaitre Vascular Raised to Strong Buy on Solid Q4 Results", "Zimmer Biomet Expands in Transcutaneous Skeletal Implants", "ResMed: SDB Market and International Investments Boost Q2", "LeMaitre Vascular Q4 Earnings, Sales Top Estimates; Up Y/Y", "Health Care Sector Update for 02/25/2016: LMAT,AMSG,HTWR", "Health Care Sector Update for 02/25/2016: TNDM,LMAT,HTWR", "Nxstage Q4 Loss in Line with Estimates, Revenues Up Y/Y", "Mixed Q3 at Haemonetics, FY16 View Strong: Hold Now", "The Zacks Analyst Blog Highlights: LogMeIn, Extreme Networks, INC Research Holdings, Netgear and LeMaitre Vascular", "Phibro Animal Health Lags Q2 Earnings, Revenues Grow Y/Y", "CVS Health Posts In-Line Earnings, Tops Revenues in Q4", "Owens & Minor Q4 Earnings Beat Estimates, Revenues Flat", "Boston Scientific Scores Earnings Beat amid CRM Headwinds", "Omnicell Q4 Earnings, Revenues Rise Y/Y; Aesynt Buyout Over", "Cepheid Incurs Loss in Q4 as Margins Drop; Revenues Up Y/Y", "Bruker (BRKR) Tops Q4 Earnings and Revenues; Margins Up", "The Zacks Analyst Blog Highlights: LogMeIn, Extreme Networks, INC Research Holdings, Netgear and LeMaitre Vascular", "Phibro Animal Health Lags Q2 Earnings, Revenues Grow Y/Y", "CVS Health Posts In-Line Earnings, Tops Revenues in Q4", "Owens & Minor Q4 Earnings Beat Estimates, Revenues Flat", "Boston Scientific Scores Earnings Beat amid CRM Headwinds", "Omnicell Q4 Earnings, Revenues Rise Y/Y; Aesynt Buyout Over", "Cepheid Incurs Loss in Q4 as Margins Drop; Revenues Up Y/Y", "Bruker (BRKR) Tops Q4 Earnings and Revenues; Margins Up", "Align Technology Tops Q4 Earnings, Revenues; Margins Drop", "Abaxis (ABAX) Beats on Q3 Earnings, Revenues Miss the Mark", "Mead Johnson Q4 Earnings, Sales Top Estimates: Fall Y/Y", "Zimmer Biomet (ZBH) Beats on Q4 Earnings, Margins Suffer", "Hologic Tops Q1 Earnings, Revenues; Revises FY16 View", "St. Jude Medical Beats Q4 Earnings by a Penny, Misses Sales", "Cardiovascular Systems (CSII) Looks Good: Stock Up 6.6%", "Stryker (SYK) Beats Q4 Earnings and Sales Estimates", "Cardiovascular Systems: Loss Narrows, Market Trends Strong", "Waters Corp. (WAT) Q4 Earnings Beat Estimates; Down Y/Y", "Cardiovascular Q2 Loss Narrower than Expected; Sales Miss", "ResMed Tops Q2 Earnings, Revenues; Cash Balance Impresses", "Illumina: Strategic NGS Tie-Ups Offer Hope amid Currency Woes", "Accuray: Strong Buy on Impressive Q2 Preliminary Results", "Thermo Fisher Tops Q4 Earnings, Affymetrix Buy in the Cards", "GNC Unveils 2015 Preliminary Outcome; Earnings Beat Likely", "Hill-Rom Poised on Welch Allyn Synergy, Currency Woes Stay", "FDA Okays Edwards Lifesciences' Sapien 3 for Partner III Trial", "Zimmer Biomet: Merger Synergy Lifts Hope amid Currency Woes", "CVS Health: '16 View Raised, Reimbursement Pressure Prevails", "Quality Systems Upgraded to Strong Buy on Bright Prospects", "Boston Scientific Launches Single-Use Ureteroscope; Up 6%", "NuVasive Strengthens in Transformative Spine, Buys Ellipse", "Ecolab Announces Deconsolidation of Venezuelan Operations", "Mazor Robotics Receives Record Order in Q4, Shares Up", "CONMED (CNMD) Seals SurgiQuest Buy, Boosts Surgical Unit", "Acadia Healthcare Inks Agreement to Acquire Priory Group", "3 Medtech Stocks that Doubled in 2015: Will the Trend Continue?", "Nxstage Medical (NXTM) Hits 52-Week High: Time to Buy?", "Baxter's IV Solutions Recalled on Possible Contamination", "LeMaitre Vascular (LMAT): Strong Buy on Estimate Revision", "3 Reasons Why LeMaitre Vascular (LMAT) Is a Great Growth Stock", "The Zacks Analyst Blog Highlights: Streamline Health Solutions, WaferGen Bio-systems, HealthEquity, Oculus Innovative Sciences and LeMaitre Vascular", "5 Growth Stocks to Buy on High Obamacare Enrollment", "Medtronic: Balanced Q2 Growth, Covidien Integration on Track", "LeMaitre Vascular (LMAT) Looks Good: Stock Rises 8%", "LeMaitre Hits 52-Week High on Solid Q3, Pipeline Strength", "NuVasive: International Business Flourishes amid Currency Woes", "LeMaitre Vascular (LMAT): Strong Buy on Estimate Revision", "3 Reasons Why LeMaitre Vascular (LMAT) Is a Great Growth Stock", "The Zacks Analyst Blog Highlights: Streamline Health Solutions, WaferGen Bio-systems, HealthEquity, Oculus Innovative Sciences and LeMaitre Vascular", "5 Growth Stocks to Buy on High Obamacare Enrollment", "Medtronic: Balanced Q2 Growth, Covidien Integration on Track", "LeMaitre Vascular (LMAT) Looks Good: Stock Rises 8%", "LeMaitre Hits 52-Week High on Solid Q3, Pipeline Strength", "NuVasive: International Business Flourishes amid Currency Woes", "Cardiovascular Systems Q1 Loss Narrower than Expected", "Zimmer Biomet (ZBH) Tops Q3 Earnings, Revenue Outlook Cut", "Zacks.com featured expert Kevin Matras highlights: CoreSite Realty, LeMaitre Vascular, Tesoro, Activision Blizzard and Tech Data", "Get Ready To Be Surprised This Earnings Season", "Baxter: A Strong Buy on FDA Approvals, Portfolio Strength", "The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals, Kindred Healthcare, BioTelemetry, LeMaitre Vascular and Envision Healthcare Holdings", "4 Healthcare Stocks to Buy on the Dip", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 18, 2015", "4 Growth Stocks That Continue to Crush Earnings Estimates", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 18, 2015", "Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge?", "Will LeMaitre Vascular (LMAT) Continue to Surge Higher? - Tale of the Tape", "CVS Health Posts Earnings Beat in Q2, Narrows Guidance - Analyst Blog", "LeMaitre Hits 52-Week High on Solid Q1 & Pipeline Strength - Analyst Blog", "ResMed Tops Q4 Earnings Estimates; Hikes Dividend - Analyst Blog", "Wright Medical Q2 Loss Wider than Expected, Sales Up Y/Y - Analyst Blog", "Affymetrix Tops Earnings, Revenues; Currency Woes to Stay - Analyst Blog", "NuVasive (NUVA) Tops Q2 Earnings, Revenues; EPS View Up - Analyst Blog", "Bruker DE-tector to Spot Explosive Traces at German Airports - Analyst Blog", "Cyberonics-Sorin Merger in the Cards; Q4 Results Awaited - Analyst Blog", "Abaxis Disappoints with Tepid Q4; AVRL Sale May Hurt Growth - Analyst Blog", "Baxter Looks to Expand in Oncology; Acquires New Portfolio - Analyst Blog", "Masimo Hits 52-Week High on Favorable Q1 & Court Verdict - Analyst Blog", "CVS Health Q1 Earnings Beat, Grow Y/Y; EPS View Raised - Analyst Blog", "Wright Medical Q1 Loss Wider than Expected, Sales Up Y/Y - Analyst Blog", "Omnicare (OCR) Q1 Earnings, Sales Top Estimates; Rise Y/Y - Analyst Blog", "Chemed Posts Stellar Q1; Beats on Earnings and Revenues - Analyst Blog", "Healthways Expands on Strategic Collaborations, Eyes Growth - Analyst Blog", "Boston Scientific Q1 Earnings in Line, '15 Sales View Bleak - Analyst Blog", "Meridian Bioscience Earnings in Line; Revenues Top in Q2 - Analyst Blog", "Hill-Rom Shines in Q1 on Trumpf Buyout, Product Innovation - Analyst Blog", "Haemonetics Lags Q4 Earnings, Revenues; FY16 View Bright - Analyst Blog", "Healthways (HWAY) Lags Q1 Earnings, Revenue Estimates - Analyst Blog", "Merit Medical (MMSI) Q1 Earnings, Revenues Beat; Rise Y/Y - Analyst Blog", "ResMed Beats Q3 Earnings by a Penny, Misses on Revenues - Analyst Blog", "Accuray's (ARAY) InCise MLC Reaches International Markets - Analyst Blog", "Mead Johnson (MJN) Tops Q1 Earnings, Sales Miss the Mark - Analyst Blog", "St. Jude Medical (STJ) Beats on Q1 Earnings, Revenues - Analyst Blog", "Universal Health Services Beats on Q1 Earnings, Revenues - Analyst Blog", "Baxter (BAX) Presents Positive Phase 3 Data for BAX 111 - Analyst Blog", "Is Patterson (PDCO) Mulling Medical Segment Divesture? - Analyst Blog", "Veeva's Latest Solution to Ease Medical Product Rollouts - Analyst Blog", "Baxter Files New Drug Application for BAX 855 in Japan - Analyst Blog", "Thoratec's HeartMate II Scores High in ENDURANCE Trial - Analyst Blog", "Baxter Amends Financial Provisions of Coherus Collaboration - Analyst Blog", "Stryker Q1 Earnings Beat, Revenues in Line; Both Up Y/Y - Analyst Blog", "Boston Scientific Allies to Grow in Chinese Endoscopic Market - Analyst Blog", "3 Stocks Under $10 with Massive Upside Potential - Analyst Blog", "Medtronic's Micra TPS: Smallest Pacemaker to Win CE Mark - Analyst Blog", "NxStage Medical Opens New Dialysis Center in Pittsburgh - Analyst Blog", "Cerner, Qualcomm to Enhance Home Healthcare - Analyst Blog", "athenahealth to Boost Health Management at Trinity Health - Analyst Blog", "Medtronic, IBM Health Unit Tie Up for Diabetes Management - Analyst Blog", "Cerner Eyes Expansion, Strategic Partnerships Key Catalyst - Analyst Blog", "Zimmer (ZMH) Extends Biomet Deal Outside Date to Jul 23 - Analyst Blog", "Akers' Distribution Deals Expand International Footprint - Analyst Blog", "Quality Systems Unveils Health Care Platform, Buys Gennius - Analyst Blog", "Walgreens Boots to Close 200 Drugstores in US, Shares Up - Analyst Blog", "Walgreens Boots (WBA) Tops Q2 Earnings, Revenues Lag - Analyst Blog", "Ecolab's 3D TRASAR CIP Program Named Product of the Year - Analyst Blog", "Cerner Teams Up to Start 'Aging in Place' Community Program - Analyst Blog", "NuVasive Poised on Balanced Growth, International Expansion - Analyst Blog", "Zimmer (ZMH) Extends Biomet Deal Outside Date to Jul 23 - Analyst Blog", "Akers' Distribution Deals Expand International Footprint - Analyst Blog", "Quality Systems Unveils Health Care Platform, Buys Gennius - Analyst Blog", "Walgreens Boots to Close 200 Drugstores in US, Shares Up - Analyst Blog", "Akers Signs Distribution Deal with ADS, Shares Surge - Analyst Blog", "Medtronic's CoreValve Gets FDA Go-Ahead for VIV Procedures - Analyst Blog", "Alere Wins FDA Nod for Strep A Test, Applies for CLIA Waiver - Analyst Blog", "Medtronic Up on Positive EverFlex Peripheral Stent Trial Data - Analyst Blog", "Cerner Enjoys Industry Recognitions, Wins EHNAC Accredition - Analyst Blog", "Medtronic Buys Dutch Diabetes Specialist Center, Stock Rises - Analyst Blog", "Healthways Completes Evaluation of Strategic Alternatives - Analyst Blog", "Medtronic's CoreValve Wins Regulatory Approval in Japan - Analyst Blog", "Akers Reports Narrower Loss in 2014, Revenues Surge Y/Y - Analyst Blog", "Neogen Lags Q3 Earnings & Revenue Estimates, Stock Down - Analyst Blog", "Baxter's HOMECHOICE CLARIA APD System Gets CE Mark - Analyst Blog", "Community Health (CYH) Divests 2 South Carolina Hospitals - Analyst Blog", "NxStage Medical Opens New Dialysis Center in Maryland - Analyst Blog", "Neogen Adds Reveal for Multi-Treenut to Food Allergen Tests - Analyst Blog", "Healthways Completes Evaluation of Strategic Alternatives - Analyst Blog", "Medtronic's CoreValve Wins Regulatory Approval in Japan - Analyst Blog", "Mettler-Toledo Scales a 52-Week High on Bullish Trends - Analyst Blog", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Why Eleven Biotherapeutics (EBIO) Could Be Positioned for a Slump - Tale of the Tape", "Veeva (VEEV) OpenKey: A Key to Customer Data Referencing - Analyst Blog", "NYSE Notice for Hanger for Non Compliance with 10-K Norms - Analyst Blog", "Abaxis' (ABAX) Decision to Divest AVRL: A Strategic Fit? - Analyst Blog", "LeMaitre Vascular a Strong Buy on Impressive Q4 - Analyst Blog", "Medtronic Gains on Positive 2-Year CoreValve Trial Data - Analyst Blog", "Medtronic Starts US DES Trial for Small Vessel CAD Patients - Analyst Blog", "Align Technology, Sirona to Jointly Expand in Orthodontics - Analyst Blog", "Boston Scientific's Heart Device Wins FDA Nod, CE Mark - Analyst Blog", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for March 18, 2015", "Baxter's BAX 817 Tests Positive for Hemophilia Treatment - Analyst Blog", "St. Jude Medical Releases Positive CardioMEMS HF Data - Analyst Blog", "Medtronic Up on Positive CoreValve Evolut R Study Results - Analyst Blog", "Boston Scientific Up on FDA Nod for WATCHMAN Device - Analyst Blog", "Medtronic Starts US DES Trial for Small Vessel CAD Patients - Analyst Blog", "Align Technology, Sirona to Jointly Expand in Orthodontics - Analyst Blog", "Boston Scientific's Heart Device Wins FDA Nod, CE Mark - Analyst Blog", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 20, 2014", "LeMaitre Vascular (LMAT) in Focus: Stock Rises 7.3% - Tale of the Tape", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for March 18, 2014", "Stryker Buys Patient Safety - Analyst Blog", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for November 18, 2013", "BSX Ends EVOLVE II Enrollment - Analyst Blog", "ResMed Completes Patient Enrollment - Analyst Blog", "LeMaitre Vascular (LMAT) Soars: Stock Adds 10.9% in Session - Tale of the Tape", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for May 20, 2014", "LeMaitre Vascular (LMAT) in Focus: Stock Rises 7.3% - Tale of the Tape", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for March 18, 2014", "PerkinElmer Launches Preeclampsia Test - Analyst Blog", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 19, 2013", "Hanger Q2 Earnings Lag, View Up - Analyst Blog", "Edwards Lifted to Neutral - Analyst Blog", "LIFE's New Solution for CNV - Analyst Blog", "Good News for EW - Setback for MDT - Analyst Blog", "Life Boosts Food Safety Portfolio - Analyst Blog", "ResMed's Patent Lawsuit Advances - Analyst Blog", "PerkinElmer Launches Preeclampsia Test - Analyst Blog", "Hanger 1Q Earnings Beat - Analyst Blog", "LeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for March 18, 2013", "PerkinElmer Beats but Q2 Earnings Fall - Analyst Blog", "Zacks #5 Rank Additions for Thursday - Tale of the Tape"], "Elapsed Time": ["JUN 16, 2020", "MAY 24, 2020", "MAY 1, 2020", "FEB 13, 2020", "FEB 7, 2020", "JAN 19, 2020", "JAN 4, 2020", "DEC 4, 2019", "JUN 16, 2020", "OCT 24, 2019", "AUG 19, 2019", "JUL 25, 2019", "JUN 21, 2019", "MAY 23, 2019", "MAY 2, 2019", "MAR 20, 2019", "OCT 24, 2019", "FEB 21, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 19, 2019", "FEB 12, 2019", "FEB 21, 2019", "NOV 16, 2018", "NOV 14, 2018", "OCT 20, 2018", "OCT 4, 2018", "SEP 4, 2018", "AUG 29, 2018", "AUG 27, 2018", "DEC 22, 2018", "AUG 20, 2018", "JUL 15, 2018", "JUL 11, 2018", "JUN 29, 2018", "JUN 17, 2018", "JUN 14, 2018", "MAY 18, 2018", "AUG 26, 2018", "APR 27, 2018", "APR 26, 2018", "APR 26, 2018", "APR 26, 2018", "APR 24, 2018", "APR 15, 2018", "APR 15, 2018", "APR 27, 2018", "APR 27, 2018", "APR 26, 2018", "APR 26, 2018", "APR 26, 2018", "APR 24, 2018", "APR 15, 2018", "APR 15, 2018", "APR 11, 2018", "JAN 16, 2018", "JAN 13, 2018", "DEC 20, 2017", "DEC 5, 2017", "NOV 20, 2017", "NOV 18, 2017", "NOV 8, 2017", "FEB 2, 2018", "OCT 27, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 24, 2017", "OCT 20, 2017", "OCT 19, 2017", "OCT 27, 2017", "SEP 27, 2017", "SEP 27, 2017", "SEP 27, 2017", "SEP 22, 2017", "SEP 18, 2017", "SEP 15, 2017", "SEP 11, 2017", "SEP 29, 2017", "SEP 27, 2017", "SEP 27, 2017", "JUL 31, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 26, 2017", "SEP 6, 2017", "AUG 21, 2017", "AUG 18, 2017", "JUL 31, 2017", "JUL 31, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 26, 2017", "SEP 6, 2017", "APR 28, 2017", "APR 27, 2017", "APR 27, 2017", "APR 27, 2017", "APR 18, 2017", "MAR 17, 2017", "NOV 16, 2016", "MAY 9, 2017", "NOV 11, 2016", "NOV 1, 2016", "OCT 27, 2016", "OCT 27, 2016", "SEP 22, 2016", "SEP 20, 2016", "SEP 20, 2016", "NOV 14, 2016", "SEP 12, 2016", "AUG 30, 2016", "AUG 17, 2016", "AUG 16, 2016", "AUG 11, 2016", "AUG 2, 2016", "AUG 2, 2016", "SEP 14, 2016", "JUL 26, 2016", "JUL 1, 2016", "JUN 29, 2016", "JUN 29, 2016", "JUN 29, 2016", "JUN 29, 2016", "JUN 28, 2016", "AUG 1, 2016", "JUN 24, 2016", "JUN 22, 2016", "JUN 22, 2016", "JUN 21, 2016", "JUN 20, 2016", "JUN 20, 2016", "JUN 17, 2016", "JUN 24, 2016", "JUN 24, 2016", "JUN 22, 2016", "JUN 14, 2016", "JUN 13, 2016", "JUN 9, 2016", "JUN 8, 2016", "JUN 17, 2016", "JUN 6, 2016", "JUN 3, 2016", "JUN 3, 2016", "MAY 31, 2016", "MAY 31, 2016", "MAY 27, 2016", "JUN 7, 2016", "MAY 24, 2016", "MAY 23, 2016", "MAY 20, 2016", "MAY 20, 2016", "MAY 16, 2016", "MAY 13, 2016", "MAY 12, 2016", "MAY 25, 2016", "MAY 24, 2016", "MAY 23, 2016", "MAY 20, 2016", "MAY 20, 2016", "MAY 16, 2016", "APR 13, 2016", "MAY 12, 2016", "MAY 10, 2016", "APR 26, 2016", "APR 20, 2016", "APR 15, 2016", "APR 15, 2016", "APR 14, 2016", "APR 13, 2016", "MAY 12, 2016", "APR 12, 2016", "APR 11, 2016", "APR 8, 2016", "APR 8, 2016", "APR 8, 2016", "APR 7, 2016", "APR 7, 2016", "APR 13, 2016", "APR 5, 2016", "MAR 24, 2016", "MAR 24, 2016", "MAR 24, 2016", "MAR 16, 2016", "MAR 10, 2016", "MAR 10, 2016", "APR 5, 2016", "MAR 2, 2016", "MAR 2, 2016", "FEB 29, 2016", "FEB 26, 2016", "FEB 25, 2016", "FEB 25, 2016", "FEB 11, 2016", "MAR 8, 2016", "FEB 11, 2016", "FEB 10, 2016", "FEB 9, 2016", "FEB 9, 2016", "FEB 8, 2016", "FEB 5, 2016", "FEB 4, 2016", "FEB 11, 2016", "FEB 11, 2016", "FEB 10, 2016", "FEB 9, 2016", "FEB 9, 2016", "FEB 8, 2016", "FEB 5, 2016", "FEB 4, 2016", "FEB 11, 2016", "JAN 29, 2016", "JAN 29, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "FEB 2, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 26, 2016", "JAN 22, 2016", "JAN 22, 2016", "JAN 22, 2016", "JAN 21, 2016", "JAN 28, 2016", "JAN 20, 2016", "JAN 19, 2016", "JAN 19, 2016", "JAN 18, 2016", "JAN 7, 2016", "JAN 7, 2016", "JAN 15, 2016", "JAN 6, 2016", "JAN 6, 2016", "JAN 6, 2016", "JAN 5, 2016", "JAN 5, 2016", "JAN 4, 2016", "DEC 31, 2015", "JAN 6, 2016", "DEC 30, 2015", "DEC 29, 2015", "DEC 22, 2015", "DEC 21, 2015", "DEC 8, 2015", "DEC 7, 2015", "NOV 23, 2015", "DEC 30, 2015", "DEC 30, 2015", "DEC 29, 2015", "DEC 22, 2015", "DEC 21, 2015", "DEC 8, 2015", "DEC 7, 2015", "NOV 23, 2015", "DEC 30, 2015", "NOV 6, 2015", "OCT 29, 2015", "OCT 7, 2015", "OCT 6, 2015", "OCT 2, 2015", "SEP 30, 2015", "SEP 29, 2015", "NOV 17, 2015", "SEP 11, 2015", "AUG 17, 2015", "AUG 14, 2015", "AUG 6, 2015", "AUG 4, 2015", "JUN 5, 2015", "JUL 31, 2015", "JUL 30, 2015", "JUL 30, 2015", "MAY 18, 2015", "MAY 18, 2015", "MAY 18, 2015", "MAY 15, 2015", "MAY 13, 2015", "MAY 20, 2015", "MAY 1, 2015", "APR 30, 2015", "APR 30, 2015", "APR 29, 2015", "APR 29, 2015", "APR 28, 2015", "APR 28, 2015", "MAY 7, 2015", "APR 28, 2015", "APR 24, 2015", "APR 24, 2015", "APR 24, 2015", "APR 23, 2015", "APR 23, 2015", "APR 22, 2015", "APR 28, 2015", "APR 20, 2015", "APR 20, 2015", "APR 17, 2015", "APR 17, 2015", "APR 17, 2015", "APR 16, 2015", "APR 22, 2015", "APR 16, 2015", "APR 15, 2015", "APR 15, 2015", "APR 15, 2015", "APR 14, 2015", "APR 14, 2015", "APR 14, 2015", "APR 16, 2015", "APR 14, 2015", "APR 14, 2015", "APR 13, 2015", "APR 10, 2015", "APR 9, 2015", "APR 9, 2015", "APR 8, 2015", "APR 14, 2015", "APR 14, 2015", "APR 14, 2015", "APR 13, 2015", "APR 10, 2015", "APR 6, 2015", "APR 6, 2015", "APR 6, 2015", "APR 8, 2015", "APR 7, 2015", "APR 7, 2015", "APR 1, 2015", "MAR 31, 2015", "MAR 31, 2015", "MAR 27, 2015", "APR 2, 2015", "APR 2, 2015", "APR 1, 2015", "APR 1, 2015", "APR 1, 2015", "MAR 31, 2015", "MAR 20, 2015", "MAR 19, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 24, 2015", "MAR 24, 2015", "MAR 23, 2015", "MAR 20, 2015", "MAR 16, 2015", "MAR 13, 2015", "MAR 19, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 13, 2015", "MAR 19, 2015", "MAY 19, 2014", "MAY 1, 2014", "MAR 17, 2014", "JAN 3, 2014", "NOV 15, 2013", "SEP 17, 2013", "SEP 4, 2013", "JUN 25, 2014", "MAY 19, 2014", "MAY 1, 2014", "MAR 17, 2014", "AUG 21, 2013", "AUG 16, 2013", "AUG 2, 2013", "SEP 3, 2013", "AUG 29, 2013", "AUG 28, 2013", "AUG 27, 2013", "AUG 26, 2013", "AUG 21, 2013", "MAY 2, 2013", "MAR 14, 2013", "AUG 2, 2013", "MAR 1, 2012"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/the-math-shows-ihi-can-go-to-%24287-2020-06-16", "https://www.nasdaq.com/articles/3-medical-supply-stocks-you-should-own-besides-medtronic-2020-05-24", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-q1-2020-earnings-call-transcript-2020-05-02", "https://www.nasdaq.com/articles/3-exciting-healthcare-stocks-2020-02-13", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-q4-2019-earnings-call-transcript-2020-02-07", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-motley-fool-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-1-4-2020-2020-01-04", "https://www.nasdaq.com/articles/commit-to-purchase-lemaitre-vascular-at-%2430-earn-10.8-annualized-using-options-2019-12-04", "https://www.nasdaq.com/articles/the-math-shows-ihi-can-go-to-%24287-2020-06-16", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-q3-2019-earnings-call-transcript-2019-10-24", "https://www.nasdaq.com/articles/lemaitre-vascular-inc.-lmat-ex-dividend-date-scheduled-for-august-20-2019-2019-08-19", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-q2-2019-earnings-call-transcript-2019-07-25", "https://www.nasdaq.com/articles/healthcare%3A-3-little-known-medical-device-makers-2019-06-21", "https://www.nasdaq.com/articles/math-shows-ihi-can-go-%24247-2019-05-23", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-q1-2019-earnings-call-transcript-2019-05-02", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-march-21-2019-2019-03-20", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-gskbioepix...-2019-10-24", "https://www.nasdaq.com/articles/validea-martin-zweig-strategy-daily-upgrade-report-2212019-2019-02-21", "https://www.nasdaq.com/articles/lmat-makes-bullish-cross-above-critical-moving-average-2019-02-20", "https://www.nasdaq.com/articles/why-lemaitre-vascular-soaring-2019-02-20", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-15-kandi-technologies-shares-spike-higher-2019-02-20", "https://www.nasdaq.com/articles/mid-day-market-update-lemaitre-vascular-surges-following-strong-q4-results-sienna", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-q4-2018-earnings-conference-call-transcript-2019-02-19", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-earnings-expected-to-grow%3A-what-to-know-ahead-of-next-weeks-release", "https://www.nasdaq.com/articles/lemaitre-vascular-reaches-analyst-target-price-2019-02-21", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-november-19-2018-2018-11-16", "https://www.nasdaq.com/articles/analysts-predict-17-gains-ahead-holdings-ijt-2018-11-14", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-october-2018-10-20", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-meets-q3-earnings-estimates-2018-10-04", "https://www.nasdaq.com/articles/commit-purchase-lemaitre-vascular-30-earn-56-annualized-using-options-2018-09-04", "https://www.nasdaq.com/articles/5-healthcare-stocks-that-are-down-but-not-out-2018-08-29", "https://www.nasdaq.com/articles/company-proves-thinking-small-can-pay-big-2018-08-27", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-right-now-2018-12-22", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-august-21-2018-2018-08-20", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-motley-fool-7152018-2018-07-15", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-7112018-2018-07-11", "https://www.nasdaq.com/articles/3-unknown-amazing-dividend-stocks-2018-06-29", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-motley-fool-6172018-2018-06-17", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-6142018-2018-06-14", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-may-21-2018-2018-05-18", "https://www.nasdaq.com/articles/3-small-cap-healthcare-stocks-your-watch-list-2018-08-26", "https://www.nasdaq.com/articles/validea-martin-zweig-strategy-daily-upgrade-report-4272018-2018-04-27", "https://www.nasdaq.com/articles/heres-why-lemaitre-vascular-inc-falling-today-2018-04-26", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-facebook-profit-tops-expectations-2018-04-26", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-rises-250-points-chipotle-shares-spike-higher-2018-04-26", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-soars-to-a-52-week-high-time-to-cash-out-2018-04-24", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-motley-fool-4152018-2018-04-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-martin-zweig-4152018-2018-04-15", "https://www.nasdaq.com/articles/validea-peter-lynch-strategy-daily-upgrade-report-4272018-2018-04-27", "https://www.nasdaq.com/articles/validea-martin-zweig-strategy-daily-upgrade-report-4272018-2018-04-27", "https://www.nasdaq.com/articles/heres-why-lemaitre-vascular-inc-falling-today-2018-04-26", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-facebook-profit-tops-expectations-2018-04-26", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-rises-250-points-chipotle-shares-spike-higher-2018-04-26", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-soars-to-a-52-week-high-time-to-cash-out-2018-04-24", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-motley-fool-4152018-2018-04-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-martin-zweig-4152018-2018-04-15", "https://www.nasdaq.com/articles/lemaitre-vascular-inc.-lmat-sees-hammer-chart-pattern%3A-time-to-buy-2018-04-11", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-right-now-2018-01-16", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-1132018-2018-01-13", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-12202017-2017-12-20", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-1252017-2017-12-05", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-november-21-2017-2017-11-20", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-11182017-2017-11-18", "https://www.nasdaq.com/articles/3-unknown-amazing-dividend-stocks-2017-11-08", "https://www.nasdaq.com/articles/validea-motley-fool-strategy-daily-upgrade-report-222018-2018-02-02", "https://www.nasdaq.com/articles/top-rated-stocks-near-buy-point-earnings-due-inogen-2017-10-27", "https://www.nasdaq.com/articles/why-lemaitre-vascular-inc-plunging-today-2017-10-27", "https://www.nasdaq.com/articles/integra-lifesciences-hld-earns-rs-rating-upgrade-2017-10-26", "https://www.nasdaq.com/articles/qiagen-shows-improved-relative-strength-still-shy-benchmark-2017-10-26", "https://www.nasdaq.com/articles/resmed-shows-rising-relative-price-performance-still-shy-key-benchmark-2017-10-24", "https://www.nasdaq.com/articles/stocks-watch-ahead-earnings-inogen-2017-10-20", "https://www.nasdaq.com/articles/stryker-syk-to-gain-from-solid-portfolio-and-acquisitions-2017-10-19", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-mimedx-2017-10-27", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-fda-approvals-portfolio-strength-2017-09-27", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-penumbra-2017-09-27", "https://www.nasdaq.com/articles/neogen-earns-membership-95-plus-composite-rating-club-2017-09-27", "https://www.nasdaq.com/articles/5-medtech-stocks-to-pick-for-stellar-returns-2017-09-22", "https://www.nasdaq.com/articles/5-medtech-stocks-to-pick-for-stellar-returns-2017-09-18", "https://www.nasdaq.com/articles/3-dividend-healthcare-stocks-2017-09-15", "https://www.nasdaq.com/articles/5-top-ranked-medtech-growth-stocks-for-solid-returns-2017-09-11", "https://www.nasdaq.com/articles/stryker-syk-to-gain-from-solid-portfolio-and-acquisitions-2017-09-29", "https://www.nasdaq.com/articles/luminex-lmnx-banks-on-fda-approvals-portfolio-strength-2017-09-27", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-penumbra-2017-09-27", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-worth-a-look%3A-stock-jumps-19.5-2017-07-31", "https://www.nasdaq.com/articles/mid-day-market-update-boston-beer-surges-earnings-beat-destination-maternity-shares-slide", "https://www.nasdaq.com/articles/health-care-sector-update-07282017-lmatcytratnm-2017-07-28", "https://www.nasdaq.com/articles/3-under-radar-stocks-healthcare-sector-2017-07-26", "https://www.nasdaq.com/articles/forget-abbott-buy-these-4-high-growth-medtech-stocks-instead-2017-09-06", "https://www.nasdaq.com/articles/why-lemaitre-vascular-lmat-could-be-positioned-for-a-surge-2017-08-21", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-august-21-2017-2017-08-18", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-july-31st-2017-07-31", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-worth-a-look%3A-stock-jumps-19.5-2017-07-31", "https://www.nasdaq.com/articles/mid-day-market-update-boston-beer-surges-earnings-beat-destination-maternity-shares-slide", "https://www.nasdaq.com/articles/health-care-sector-update-07282017-lmatcytratnm-2017-07-28", "https://www.nasdaq.com/articles/3-under-radar-stocks-healthcare-sector-2017-07-26", "https://www.nasdaq.com/articles/forget-abbott-buy-these-4-high-growth-medtech-stocks-instead-2017-09-06", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-april-28th-2017-04-28", "https://www.nasdaq.com/articles/heres-why-lemaitre-vascular-stock-soaring-today-2017-04-27", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-down-2-grubhub-shares-surge-earnings-beat-2017-04-27", "https://www.nasdaq.com/articles/mid-afternoon-market-update-lemaitre-vascular-rises-after-strong-q1-results-synchronoss", "https://www.nasdaq.com/articles/medical-device-stocks-to-beat-estimates-this-earnings-season-2017-04-18", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-march-20-2017-2017-03-17", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-november-17-2016-2016-11-16", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-lemaitre-vascular-lmat-2017-05-09", "https://www.nasdaq.com/articles/lemaitre-vascular-buys-restore-flow-allografts-for-%2414m-2016-11-11", "https://www.nasdaq.com/articles/is-lemaitre-vascular-lmat-great-growth-stock-2016-11-01", "https://www.nasdaq.com/articles/mid-day-market-update-gnc-falls-after-weak-q3-results-ocwen-financial-shares-surge-2016-10", "https://www.nasdaq.com/articles/mid-afternoon-market-update-ttm-tech-climbs-earnings-beat-groupon-shares-plummet-2016-10", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-22-omnova-shares-drop-earnings-miss-2016-09-22", "https://www.nasdaq.com/articles/is-lemaitre-vascular-lmat-a-great-growth-stock-2016-09-20", "https://www.nasdaq.com/articles/can-the-rally-in-lemaitre-vascular-lmat-shares-continue-2016-09-20", "https://www.nasdaq.com/articles/lemaitre-lmat-hits-a-52-week-high-on-strategic-buyout-2016-11-14", "https://www.nasdaq.com/articles/3-reasons-why-lemaitre-vascular-lmat-is-a-great-momentum-stock-2016-09-12", "https://www.nasdaq.com/articles/4-stocks-strong-technical-patterns-2016-08-30", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-august-18-2016-2016-08-17", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-lemaitre-vascular-lmat-2016-08-16", "https://www.nasdaq.com/articles/will-lemaitre-vascular-lmat-continue-to-surge-higher-2016-08-11", "https://www.nasdaq.com/articles/cvs-health-cvs-tops-q2-earnings-lags-on-revenue-view-up-2016-08-02", "https://www.nasdaq.com/articles/omnicell-omcl-tops-q2-earnings-revenues-margins-drag-2016-08-02", "https://www.nasdaq.com/articles/lemaitre-hits-52-week-high-on-strong-international-presence-2016-09-14", "https://www.nasdaq.com/articles/why-cryolife-incs-shares-turned-hot-today-2016-07-26", "https://www.nasdaq.com/articles/myriad-genetics%3A-study-data-drives-growth-competition-rife-2016-07-01", "https://www.nasdaq.com/articles/illumina-molecularmd-to-co-develop-oncology-diagnostics-2016-06-29", "https://www.nasdaq.com/articles/steris%3A-synergy-health-deal-to-drive-growth-competition-rife-2016-06-29", "https://www.nasdaq.com/articles/medtronic-positive-on-heartware-buy-covidien-synergies-2016-06-29", "https://www.nasdaq.com/articles/bruker-poised-on-product-launches-amid-near-term-risks-2016-06-29", "https://www.nasdaq.com/articles/medtronic-to-boost-heart-failure-business-with-heartware-buy-2016-06-28", "https://www.nasdaq.com/articles/cerus-cers-in-focus%3A-stock-moves-6-higher-in-session-2016-08-01", "https://www.nasdaq.com/articles/fda-okays-trial-for-medtronics-mri-guided-epilepsy-device-2016-06-24", "https://www.nasdaq.com/articles/hologic%3A-fda-okays-procleix-zika-virus-test-under-ind-study-2016-06-22", "https://www.nasdaq.com/articles/walgreen-boots-hopeful-on-rite-aid-buyout-amid-margin-woes-2016-06-22", "https://www.nasdaq.com/articles/qiagens-q1-results-hit-by-currency-competition-rife-2016-06-21", "https://www.nasdaq.com/articles/hill-rom-introduces-visivest-first-connected-airways-system-2016-06-20", "https://www.nasdaq.com/articles/hologics-zika-virus-test-gets-fda-nod-for-emergency-use-2016-06-20", "https://www.nasdaq.com/articles/amsurg-envision-healthcare-set-to-merge-by-2016-end-2016-06-17", "https://www.nasdaq.com/articles/genomic-health%3A-can-the-liquid-biopsy-test-boost-margins-2016-06-24", "https://www.nasdaq.com/articles/fda-okays-trial-for-medtronics-mri-guided-epilepsy-device-2016-06-24", "https://www.nasdaq.com/articles/hologic%3A-fda-okays-procleix-zika-virus-test-under-ind-study-2016-06-22", "https://www.nasdaq.com/articles/boston-scientific%3A-restructuring-plan-global-growth-impress-2016-06-14", "https://www.nasdaq.com/articles/petmed-remains-strong-on-new-order-reorder-sales-gain-2016-06-13", "https://www.nasdaq.com/articles/haemonetics%3A-q4-hit-by-issues-in-russia-currency-woes-stay-2016-06-09", "https://www.nasdaq.com/articles/hill-rom%3A-welch-allyn-buyout-drives-q2-forex-woes-stay-2016-06-08", "https://www.nasdaq.com/articles/genomic-health-brings-liquid-biopsy-test-for-stage-iv-cancer-2016-06-17", "https://www.nasdaq.com/articles/abaxis-abax%3A-solid-veterinary-show-despite-global-hiccups-2016-06-06", "https://www.nasdaq.com/articles/henry-schein%3A-q1-results-strong-expansion-plans-on-track-2016-06-03", "https://www.nasdaq.com/articles/medtronic-mdt-posts-solid-q4-covidien-synergy-continues-2016-06-03", "https://www.nasdaq.com/articles/medtronic-mdt-beats-q4-earnings-revenue-estimates-2016-05-31", "https://www.nasdaq.com/articles/nuvasive-poised-on-solid-international-sales-scope-in-spine-2016-05-31", "https://www.nasdaq.com/articles/medtronic-mdt%3A-will-currency-woes-hurt-q4-as-well-2016-05-27", "https://www.nasdaq.com/articles/hologic%3A-q2-strong-on-segmental-expansion-competition-rife-2016-06-07", "https://www.nasdaq.com/articles/genomic-health-ghdx%3A-q1-results-strong-costs-escalate-2016-05-24", "https://www.nasdaq.com/articles/steris-ste%3A-q4-results-strong-currency-woes-remain-2016-05-23", "https://www.nasdaq.com/articles/boston-scientifics-full-body-mri-scs-system-gets-fda-nod-2016-05-20", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-may-23-2016-2016-05-20", "https://www.nasdaq.com/articles/myriad-genetics%3A-test-revenues-strong-currency-woes-stay-2016-05-16", "https://www.nasdaq.com/articles/vwr-corp-posts-strong-q1-results-gross-margins-weak-2016-05-13", "https://www.nasdaq.com/articles/illumina%3A-q1-results-hit-by-soaring-costs-16-view-down-2016-05-12", "https://www.nasdaq.com/articles/abaxis-abax-posts-solid-q4-amid-international-headwind-2016-05-25", "https://www.nasdaq.com/articles/genomic-health-ghdx%3A-q1-results-strong-costs-escalate-2016-05-24", "https://www.nasdaq.com/articles/steris-ste%3A-q4-results-strong-currency-woes-remain-2016-05-23", "https://www.nasdaq.com/articles/boston-scientifics-full-body-mri-scs-system-gets-fda-nod-2016-05-20", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-may-23-2016-2016-05-20", "https://www.nasdaq.com/articles/myriad-genetics%3A-test-revenues-strong-currency-woes-stay-2016-05-16", "https://www.nasdaq.com/articles/edwards-lifesciences-solid-pipeline-product-suite-impress-2016-04-13", "https://www.nasdaq.com/articles/boston-scientific-bsx%3A-q1-earnings-beat-amid-crm-woes-2016-05-12", "https://www.nasdaq.com/articles/phibro-animal-pahc-misses-q3-earnings-on-low-revenues-2016-05-10", "https://www.nasdaq.com/articles/baxter-international-bax-q1-earnings-sales-beat-view-up-2016-04-26", "https://www.nasdaq.com/articles/st.-jude-medical-stj-q1-earnings-beat-on-high-hf-sales-2016-04-20", "https://www.nasdaq.com/articles/quest-diagnostics%3A-expanded-use-of-hcv-test-services-2016-04-15", "https://www.nasdaq.com/articles/gnc-holdings%3A-retail-a-bright-spot-cash-balance-strong-2016-04-15", "https://www.nasdaq.com/articles/boston-scientific-bsx%3A-international-growth-amid-crm-woes-2016-04-14", "https://www.nasdaq.com/articles/edwards-lifesciences-solid-pipeline-product-suite-impress-2016-04-13", "https://www.nasdaq.com/articles/boston-scientific-bsx%3A-q1-earnings-beat-amid-crm-woes-2016-05-12", "https://www.nasdaq.com/articles/parexel-prxl%3A-a-strong-buy-on-solid-estimate-revisions-2016-04-12", "https://www.nasdaq.com/articles/phibro-animal-declines-as-fda-moves-to-revoke-mecadox-2016-04-11", "https://www.nasdaq.com/articles/angiodynamics-tops-q3-earnings-sales-fy16-view-pruned-2016-04-08", "https://www.nasdaq.com/articles/resmed%3A-strong-cash-balance-product-portfolio-drive-growth-2016-04-08", "https://www.nasdaq.com/articles/medtronics-micra-tps-miniature-pacemaker-gets-fda-nod-2016-04-08", "https://www.nasdaq.com/articles/what-makes-eagle-pharmaceuticals-egrx-a-strong-sell-2016-04-07", "https://www.nasdaq.com/articles/edwards-lifesciences-up-on-positive-partner-ii-trial-data-2016-04-07", "https://www.nasdaq.com/articles/myriad-genetics%3A-solid-product-suite-currency-hurts-stock-2016-04-13", "https://www.nasdaq.com/articles/medtronic%3A-3-year-corevalve-data-positive-in-high-risk-study-2016-04-05", "https://www.nasdaq.com/articles/akers-biosciences-protein-preparation-gets-patent-cover-2016-03-24", "https://www.nasdaq.com/articles/cepheid%3A-test-menu-expansion-strong-currency-woes-stay-2016-03-24", "https://www.nasdaq.com/articles/boston-scientific-unveils-stent-for-pancreatitis-complications-2016-03-24", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-march-17-2016-2016-03-16", "https://www.nasdaq.com/articles/baxter-bax-now-a-strong-buy-on-solid-estimate-revisions-2016-03-10", "https://www.nasdaq.com/articles/fda-okays-cepheid-xpert-carba-r-for-drug-resistant-genes-2016-03-10", "https://www.nasdaq.com/articles/walgreens-boots-tops-q2-earnings-rite-aid-deal-in-focus-2016-04-05", "https://www.nasdaq.com/articles/lemaitre-vascular-raised-to-strong-buy-on-solid-q4-results-2016-03-02", "https://www.nasdaq.com/articles/zimmer-biomet-expands-in-transcutaneous-skeletal-implants-2016-03-02", "https://www.nasdaq.com/articles/resmed%3A-sdb-market-and-international-investments-boost-q2-2016-02-29", "https://www.nasdaq.com/articles/lemaitre-vascular-q4-earnings-sales-top-estimates-up-y-y-2016-02-26", "https://www.nasdaq.com/articles/health-care-sector-update-02252016-lmatamsghtwr-2016-02-25", "https://www.nasdaq.com/articles/health-care-sector-update-02252016-tndmlmathtwr-2016-02-25", "https://www.nasdaq.com/articles/nxstage-q4-loss-in-line-with-estimates-revenues-up-y-y-2016-02-11", "https://www.nasdaq.com/articles/mixed-q3-at-haemonetics-fy16-view-strong%3A-hold-now-2016-03-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-logmein-extreme-networks-inc-research-holdings-netgear", "https://www.nasdaq.com/articles/phibro-animal-health-lags-q2-earnings-revenues-grow-y-y-2016-02-10", "https://www.nasdaq.com/articles/cvs-health-posts-in-line-earnings-tops-revenues-in-q4-2016-02-09", "https://www.nasdaq.com/articles/owens-minor-q4-earnings-beat-estimates-revenues-flat-2016-02-09", "https://www.nasdaq.com/articles/boston-scientific-scores-earnings-beat-amid-crm-headwinds-2016-02-08", "https://www.nasdaq.com/articles/omnicell-q4-earnings-revenues-rise-y-y-aesynt-buyout-over-2016-02-05", "https://www.nasdaq.com/articles/cepheid-incurs-loss-in-q4-as-margins-drop-revenues-up-y-y-2016-02-04", "https://www.nasdaq.com/articles/bruker-brkr-tops-q4-earnings-and-revenues-margins-up-2016-02-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-logmein-extreme-networks-inc-research-holdings-netgear", "https://www.nasdaq.com/articles/phibro-animal-health-lags-q2-earnings-revenues-grow-y-y-2016-02-10", "https://www.nasdaq.com/articles/cvs-health-posts-in-line-earnings-tops-revenues-in-q4-2016-02-09", "https://www.nasdaq.com/articles/owens-minor-q4-earnings-beat-estimates-revenues-flat-2016-02-09", "https://www.nasdaq.com/articles/boston-scientific-scores-earnings-beat-amid-crm-headwinds-2016-02-08", "https://www.nasdaq.com/articles/omnicell-q4-earnings-revenues-rise-y-y-aesynt-buyout-over-2016-02-05", "https://www.nasdaq.com/articles/cepheid-incurs-loss-in-q4-as-margins-drop-revenues-up-y-y-2016-02-04", "https://www.nasdaq.com/articles/bruker-brkr-tops-q4-earnings-and-revenues-margins-up-2016-02-11", "https://www.nasdaq.com/articles/align-technology-tops-q4-earnings-revenues-margins-drop-2016-01-29", "https://www.nasdaq.com/articles/abaxis-abax-beats-on-q3-earnings-revenues-miss-the-mark-2016-01-29", "https://www.nasdaq.com/articles/mead-johnson-q4-earnings-sales-top-estimates%3A-fall-y-y-2016-01-28", "https://www.nasdaq.com/articles/zimmer-biomet-zbh-beats-on-q4-earnings-margins-suffer-2016-01-28", "https://www.nasdaq.com/articles/hologic-tops-q1-earnings-revenues-revises-fy16-view-2016-01-28", "https://www.nasdaq.com/articles/st.-jude-medical-beats-q4-earnings-by-a-penny-misses-sales-2016-01-28", "https://www.nasdaq.com/articles/cardiovascular-systems-csii-looks-good%3A-stock-up-6.6-2016-02-02", "https://www.nasdaq.com/articles/stryker-syk-beats-q4-earnings-and-sales-estimates-2016-01-27", "https://www.nasdaq.com/articles/cardiovascular-systems%3A-loss-narrows-market-trends-strong-2016-01-27", "https://www.nasdaq.com/articles/waters-corp.-wat-q4-earnings-beat-estimates-down-y-y-2016-01-26", "https://www.nasdaq.com/articles/cardiovascular-q2-loss-narrower-than-expected-sales-miss-2016-01-22", "https://www.nasdaq.com/articles/resmed-tops-q2-earnings-revenues-cash-balance-impresses-2016-01-22", "https://www.nasdaq.com/articles/illumina%3A-strategic-ngs-tie-ups-offer-hope-amid-currency-woes-2016-01-22", "https://www.nasdaq.com/articles/accuray%3A-strong-buy-on-impressive-q2-preliminary-results-2016-01-21", "https://www.nasdaq.com/articles/thermo-fisher-tops-q4-earnings-affymetrix-buy-in-the-cards-2016-01-28", "https://www.nasdaq.com/articles/gnc-unveils-2015-preliminary-outcome-earnings-beat-likely-2016-01-20", "https://www.nasdaq.com/articles/hill-rom-poised-on-welch-allyn-synergy-currency-woes-stay-2016-01-19", "https://www.nasdaq.com/articles/fda-okays-edwards-lifesciences-sapien-3-for-partner-iii-trial-2016-01-19", "https://www.nasdaq.com/articles/zimmer-biomet%3A-merger-synergy-lifts-hope-amid-currency-woes-2016-01-18", "https://www.nasdaq.com/articles/cvs-health%3A-16-view-raised-reimbursement-pressure-prevails-2016-01-07", "https://www.nasdaq.com/articles/quality-systems-upgraded-to-strong-buy-on-bright-prospects-2016-01-07", "https://www.nasdaq.com/articles/boston-scientific-launches-single-use-ureteroscope-up-6-2016-01-15", "https://www.nasdaq.com/articles/nuvasive-strengthens-in-transformative-spine-buys-ellipse-2016-01-06", "https://www.nasdaq.com/articles/ecolab-announces-deconsolidation-of-venezuelan-operations-2016-01-06", "https://www.nasdaq.com/articles/mazor-robotics-receives-record-order-in-q4-shares-up-2016-01-06", "https://www.nasdaq.com/articles/conmed-cnmd-seals-surgiquest-buy-boosts-surgical-unit-2016-01-05", "https://www.nasdaq.com/articles/acadia-healthcare-inks-agreement-to-acquire-priory-group-2016-01-05", "https://www.nasdaq.com/articles/3-medtech-stocks-that-doubled-in-2015%3A-will-the-trend-continue-2016-01-04", "https://www.nasdaq.com/articles/nxstage-medical-nxtm-hits-52-week-high%3A-time-to-buy-2015-12-31", "https://www.nasdaq.com/articles/baxters-iv-solutions-recalled-on-possible-contamination-2016-01-06", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat%3A-strong-buy-on-estimate-revision-2015-12-30", "https://www.nasdaq.com/articles/3-reasons-why-lemaitre-vascular-lmat-is-a-great-growth-stock-2015-12-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-streamline-health-solutions-wafergen-bio-systems", "https://www.nasdaq.com/articles/5-growth-stocks-buy-high-obamacare-enrollment-2015-12-21", "https://www.nasdaq.com/articles/medtronic%3A-balanced-q2-growth-covidien-integration-on-track-2015-12-08", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-looks-good%3A-stock-rises-8-2015-12-07", "https://www.nasdaq.com/articles/lemaitre-hits-52-week-high-on-solid-q3-pipeline-strength-2015-11-23", "https://www.nasdaq.com/articles/nuvasive%3A-international-business-flourishes-amid-currency-woes-2015-12-30", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat%3A-strong-buy-on-estimate-revision-2015-12-30", "https://www.nasdaq.com/articles/3-reasons-why-lemaitre-vascular-lmat-is-a-great-growth-stock-2015-12-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-streamline-health-solutions-wafergen-bio-systems", "https://www.nasdaq.com/articles/5-growth-stocks-buy-high-obamacare-enrollment-2015-12-21", "https://www.nasdaq.com/articles/medtronic%3A-balanced-q2-growth-covidien-integration-on-track-2015-12-08", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-looks-good%3A-stock-rises-8-2015-12-07", "https://www.nasdaq.com/articles/lemaitre-hits-52-week-high-on-solid-q3-pipeline-strength-2015-11-23", "https://www.nasdaq.com/articles/nuvasive%3A-international-business-flourishes-amid-currency-woes-2015-12-30", "https://www.nasdaq.com/articles/cardiovascular-systems-q1-loss-narrower-than-expected-2015-11-06", "https://www.nasdaq.com/articles/zimmer-biomet-zbh-tops-q3-earnings-revenue-outlook-cut-2015-10-29", "https://www.nasdaq.com/articles/zacks.com-featured-expert-kevin-matras-highlights%3A-coresite-realty-lemaitre-vascular", "https://www.nasdaq.com/articles/get-ready-be-surprised-earnings-season-2015-10-06", "https://www.nasdaq.com/articles/baxter%3A-a-strong-buy-on-fda-approvals-portfolio-strength-2015-10-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-valeant-pharmaceuticals-kindred-healthcare-biotelemetry", "https://www.nasdaq.com/articles/4-healthcare-stocks-to-buy-on-the-dip-2015-09-29", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-november-18-2015-2015-11-17", "https://www.nasdaq.com/articles/4-growth-stocks-that-continue-to-crush-earnings-estimates-2015-09-11", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-august-18-2015-2015-08-17", "https://www.nasdaq.com/articles/why-lemaitre-vascular-lmat-could-be-positioned-for-a-surge-2015-08-14", "https://www.nasdaq.com/articles/will-lemaitre-vascular-lmat-continue-to-surge-higher-tale-of-the-tape-2015-08-06", "https://www.nasdaq.com/articles/cvs-health-posts-earnings-beat-in-q2-narrows-guidance-analyst-blog-2015-08-04", "https://www.nasdaq.com/articles/lemaitre-hits-52-week-high-on-solid-q1-pipeline-strength-analyst-blog-2015-06-05", "https://www.nasdaq.com/articles/resmed-tops-q4-earnings-estimates-hikes-dividend-analyst-blog-2015-07-31", "https://www.nasdaq.com/articles/wright-medical-q2-loss-wider-than-expected-sales-up-y-y-analyst-blog-2015-07-30", "https://www.nasdaq.com/articles/affymetrix-tops-earnings-revenues-currency-woes-to-stay-analyst-blog-2015-07-30", "https://www.nasdaq.com/articles/akers-biosciences-down-on-wider-q1-loss-sales-fall-y-y-analyst-blog-2015-05-18", "https://www.nasdaq.com/articles/bruker-de-tector-to-spot-explosive-traces-at-german-airports-analyst-blog-2015-05-18", "https://www.nasdaq.com/articles/cyberonics-sorin-merger-in-the-cards-q4-results-awaited-analyst-blog-2015-05-18", "https://www.nasdaq.com/articles/abaxis-disappoints-with-tepid-q4-avrl-sale-may-hurt-growth-analyst-blog-2015-05-15", "https://www.nasdaq.com/articles/baxter-looks-to-expand-in-oncology-acquires-new-portfolio-analyst-blog-2015-05-13", "https://www.nasdaq.com/articles/masimo-hits-52-week-high-on-favorable-q1-court-verdict-analyst-blog-2015-05-20", "https://www.nasdaq.com/articles/cvs-health-q1-earnings-beat-grow-y-y-eps-view-raised-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/wright-medical-q1-loss-wider-than-expected-sales-up-y-y-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/omnicare-ocr-q1-earnings-sales-top-estimates-rise-y-y-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/chemed-posts-stellar-q1-beats-on-earnings-and-revenues-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/healthways-expands-on-strategic-collaborations-eyes-growth-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/boston-scientific-q1-earnings-in-line-15-sales-view-bleak-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/meridian-bioscience-earnings-in-line-revenues-top-in-q2-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/hill-rom-shines-in-q1-on-trumpf-buyout-product-innovation-analyst-blog-2015-05-07", "https://www.nasdaq.com/articles/haemonetics-lags-q4-earnings-revenues-fy16-view-bright-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/healthways-hway-lags-q1-earnings-revenue-estimates-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/merit-medical-mmsi-q1-earnings-revenues-beat-rise-y-y-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/resmed-beats-q3-earnings-by-a-penny-misses-on-revenues-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/accurays-aray-incise-mlc-reaches-international-markets-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/mead-johnson-mjn-tops-q1-earnings-sales-miss-the-mark-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/st.-jude-medical-stj-beats-on-q1-earnings-revenues-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/universal-health-services-beats-on-q1-earnings-revenues-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/baxter-bax-presents-positive-phase-3-data-for-bax-111-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/is-patterson-pdco-mulling-medical-segment-divesture-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/veevas-latest-solution-to-ease-medical-product-rollouts-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/baxter-files-new-drug-application-for-bax-855-in-japan-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/thoratecs-heartmate-ii-scores-high-in-endurance-trial-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/baxter-amends-financial-provisions-of-coherus-collaboration-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/stryker-q1-earnings-beat-revenues-in-line-both-up-y-y-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/boston-scientific-allies-to-grow-in-chinese-endoscopic-market-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/3-stocks-under-10-massive-upside-potential-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/medtronics-micra-tps%3A-smallest-pacemaker-to-win-ce-mark-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/nxstage-medical-opens-new-dialysis-center-in-pittsburgh-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/cerner-qualcomm-to-enhance-home-healthcare-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/athenahealth-to-boost-health-management-at-trinity-health-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/medtronic-ibm-health-unit-tie-up-for-diabetes-management-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/cerner-eyes-expansion-strategic-partnerships-key-catalyst-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/zimmer-zmh-extends-biomet-deal-outside-date-to-jul-23-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/akers-distribution-deals-expand-international-footprint-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/quality-systems-unveils-health-care-platform-buys-gennius-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/walgreens-boots-to-close-200-drugstores-in-us-shares-up-analyst-blog-2015-04-10", "https://www.nasdaq.com/articles/walgreens-boots-wba-tops-q2-earnings-revenues-lag-analyst-blog-2015-04-09", "https://www.nasdaq.com/articles/ecolabs-3d-trasar-cip-program-named-product-of-the-year-analyst-blog-2015-04-09", "https://www.nasdaq.com/articles/cerner-teams-up-to-start-aging-in-place-community-program-analyst-blog-2015-04-08", "https://www.nasdaq.com/articles/nuvasive-poised-on-balanced-growth-international-expansion-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/zimmer-zmh-extends-biomet-deal-outside-date-to-jul-23-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/akers-distribution-deals-expand-international-footprint-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/quality-systems-unveils-health-care-platform-buys-gennius-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/enzymotec-enzy-in-focus%3A-stock-moves-8.1-higher-tale-of-the-tape-2015-04-06", "https://www.nasdaq.com/articles/akers-signs-distribution-deal-with-ads-shares-surge-analyst-blog-2015-04-06", "https://www.nasdaq.com/articles/medtronics-corevalve-gets-fda-go-ahead-for-viv-procedures-analyst-blog-2015-04-06", "https://www.nasdaq.com/articles/alere-wins-fda-nod-for-strep-a-test-applies-for-clia-waiver-analyst-blog-2015-04-06", "https://www.nasdaq.com/articles/medtronic-up-on-positive-everflex-peripheral-stent-trial-data-analyst-blog-2015-04-08", "https://www.nasdaq.com/articles/cerner-enjoys-industry-recognitions-wins-ehnac-accredition-analyst-blog-2015-04-07", "https://www.nasdaq.com/articles/medtronic-buys-dutch-diabetes-specialist-center-stock-rises-analyst-blog-2015-04-07", "https://www.nasdaq.com/articles/healthways-completes-evaluation-of-strategic-alternatives-analyst-blog-2015-04-01", "https://www.nasdaq.com/articles/medtronics-corevalve-wins-regulatory-approval-in-japan-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/akers-reports-narrower-loss-in-2014-revenues-surge-y-y-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/neogen-lags-q3-earnings-revenue-estimates-stock-down-analyst-blog-2015-03-27", "https://www.nasdaq.com/articles/baxters-homechoice-claria-apd-system-gets-ce-mark-analyst-blog-2015-04-02", "https://www.nasdaq.com/articles/community-health-cyh-divests-2-south-carolina-hospitals-analyst-blog-2015-04-02", "https://www.nasdaq.com/articles/nxstage-medical-opens-new-dialysis-center-in-maryland-analyst-blog-2015-04-01", "https://www.nasdaq.com/articles/neogen-adds-reveal-for-multi-treenut-to-food-allergen-tests-analyst-blog-2015-04-01", "https://www.nasdaq.com/articles/healthways-completes-evaluation-of-strategic-alternatives-analyst-blog-2015-04-01", "https://www.nasdaq.com/articles/medtronics-corevalve-wins-regulatory-approval-in-japan-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/mettler-toledo-scales-a-52-week-high-on-bullish-trends-analyst-blog-2015-03-20", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2015-03-19", "https://www.nasdaq.com/articles/why-eleven-biotherapeutics-ebio-could-be-positioned-for-a-slump-tale-of-the-tape-2015-03", "https://www.nasdaq.com/articles/veeva-veev-openkey%3A-a-key-to-customer-data-referencing-analyst-blog-2015-03-25", "https://www.nasdaq.com/articles/nyse-notice-for-hanger-for-non-compliance-with-10-k-norms-analyst-blog-2015-03-24", "https://www.nasdaq.com/articles/abaxis-abax-decision-to-divest-avrl%3A-a-strategic-fit-analyst-blog-2015-03-24", "https://www.nasdaq.com/articles/lemaitre-vascular-a-strong-buy-on-impressive-q4-analyst-blog-2015-03-23", "https://www.nasdaq.com/articles/boston-scientific-up-on-fda-nod-for-watchman-device-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/medtronic-starts-us-des-trial-for-small-vessel-cad-patients-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/align-technology-sirona-to-jointly-expand-in-orthodontics-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/boston-scientifics-heart-device-wins-fda-nod-ce-mark-analyst-blog-2015-03-19", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-march-18-2015-2015-03-17", "https://www.nasdaq.com/articles/baxters-bax-817-tests-positive-for-hemophilia-treatment-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/st.-jude-medical-releases-positive-cardiomems-hf-data-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/medtronic-up-on-positive-corevalve-evolut-r-study-results-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/boston-scientific-up-on-fda-nod-for-watchman-device-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/medtronic-starts-us-des-trial-for-small-vessel-cad-patients-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/align-technology-sirona-to-jointly-expand-in-orthodontics-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/boston-scientifics-heart-device-wins-fda-nod-ce-mark-analyst-blog-2015-03-19", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-may-20-2014-2014-05-19", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-in-focus%3A-stock-rises-7.3-tale-of-the-tape-2014-05-01", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-march-18-2014-2014-03-17", "https://www.nasdaq.com/articles/stryker-buys-patient-safety-analyst-blog-2014-01-03", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-november-18-2013-2013-11-15", "https://www.nasdaq.com/articles/bsx-ends-evolve-ii-enrollment-analyst-blog-2013-09-17", "https://www.nasdaq.com/articles/resmed-completes-patient-enrollment-analyst-blog-2013-09-04", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-soars%3A-stock-adds-10.9-in-session-tale-of-the-tape-2014-06-25", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-may-20-2014-2014-05-19", "https://www.nasdaq.com/articles/lemaitre-vascular-lmat-in-focus%3A-stock-rises-7.3-tale-of-the-tape-2014-05-01", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-march-18-2014-2014-03-17", "https://www.nasdaq.com/articles/perkinelmer-launches-preeclampsia-test-analyst-blog-2013-08-21", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-august-19-2013-2013-08-16", "https://www.nasdaq.com/articles/hanger-q2-earnings-lag-view-up-analyst-blog-2013-08-02", "https://www.nasdaq.com/articles/edwards-lifted-to-neutral-analyst-blog-2013-09-03", "https://www.nasdaq.com/articles/lifes-new-solution-for-cnv-analyst-blog-2013-08-29", "https://www.nasdaq.com/articles/good-news-for-ew-setback-for-mdt-analyst-blog-2013-08-28", "https://www.nasdaq.com/articles/life-boosts-food-safety-portfolio-analyst-blog-2013-08-27", "https://www.nasdaq.com/articles/resmeds-patent-lawsuit-advances-analyst-blog-2013-08-26", "https://www.nasdaq.com/articles/symmetry-1q-earnings-disappoint-analyst-blog-2013-05-03", "https://www.nasdaq.com/articles/hanger-1q-earnings-beat-analyst-blog-2013-05-02", "https://www.nasdaq.com/articles/lemaitre-vascular-inc-lmat-ex-dividend-date-scheduled-march-18-2013-2013-03-14", "https://www.nasdaq.com/articles/perkinelmer-beats-but-q2-earnings-fall-analyst-blog-2013-08-02", "https://www.nasdaq.com/articles/zacks-5-rank-additions-for-thursday-tale-of-the-tape-2012-03-01"], "Content": []}